Notable Labs

Personalized combination therapies for cancer patients.

News and Press

Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer

MedCity News • April 15, 2019

Researchers at Stanford took blood samples from patients and sent them to Chicago-based Tempus for genomic sequencing of the person’s cancer. Another sample was sent to Notable, which used its AI-based automated laboratory system to test hundreds of potential drug treatments against the disease and provided treatment recommendations based on that analysis. Stanford clinicians then used this data (alongside the clinical features of the patient) to create a report with individualized recommendations that could inform future treatment.

Peninsula biotech's nonprofit deal spotlights unique attack on cancer in kids

San Francisco Business Times • Jan. 22, 2019

The partnership between for-profit Notable Labs and nonprofit Cures Within Reach could bring a childhood cancer treatment — a combination discovered by Foster City's Notable Labs of a generic drug and a natural product — to market faster and cheaper.

Show all News and Press (4 more)

Blog Posts

Notable Labs Presents Data Demonstrating PPMP’s Potential to Identify Novel Drug Combinations in JMML at the 2023 EHA Hybrid Congress

June 9, 2023

Clinical Laboratory Scientist (CLS)

April 27, 2023

Predictive precision medicine platform accurately predicts individual patient response to AML treatments to maximize outcomes

April 18, 2023

Notable Labs Presents Clinical Platform Validation Data at the 2023 AACR Conference

April 18, 2023
Show all Blog Posts (63 more)